Oncology Today with Dr Neil Love cover image

Metastatic Bladder Cancer — Rapid Case Review Issue 3

Oncology Today with Dr Neil Love

00:00

Sequencing: erdafitinib versus HER2 ADC

He favors erdafitinib first given randomized THOR trial evidence, reserving HER2 ADCs per smaller tumor‑agnostic data.

Play episode from 21:09
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app